Prise en charge des otites séromuqueuses de l’enfant. Recommandations de pratiques cliniques (RPC) de la Société française d’ORL et de chirurgie cervico-faciale
F. Blanc(Hôpital Gui de Chauliac), M. Mondain, Olivier Déguine(Centre Hospitalier Universitaire de Toulouse), V. Franco‐Vidal(RELX Group (Netherlands)), M. François(Assistance Publique – Hôpitaux de Paris), S. Tringali, Natacha Tessier(The University of Melbourne), J. Nevoux(Bicêtre Hospital), R. Marianowski, P. Bordure(Centre Hospitalier Universitaire de Nantes), Nicolas Leboulanger(Hôpital Necker-Enfants Malades), D. Ayache(Fondation de Rothschild), R. Nicollas(Hôpital de la Timone), M. Calmels(Centre Hospitalier Universitaire de Toulouse), E. Lescanne(Centre Hospitalier Universitaire de Tours)
Annales françaises d Oto-rhino-laryngologie et de Pathologie Cervico-faciale
September 1, 2018
Cited by 4
Related Papers
GJB2 Mutations and Degree of Hearing Loss: A Multicenter Study
|The American Journal of Human Genetics|2005|558
Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma
|International Journal of Pediatric Otorhinolaryngology|2009|235
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30‐year nationwide cohort of 1478 patients under 18 years of age
|British Journal of Haematology|2016|130
Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: A preliminary retrospective study of French experience
|International Journal of Pediatric Otorhinolaryngology|2010|110
Laryngo-tracheo-oesophageal clefts
|Orphanet Journal of Rare Diseases|2011|105